StonvexLoading…
StonvexStonvexStonvexCore line items from ISRG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.06B | $8.35B | $7.12B | $6.22B |
Operating Income | $2.95B | $2.35B | $1.77B | $1.58B |
Net Income | $2.86B | $2.32B | $1.80B | $1.32B |
EPS (Diluted) | $7.87 | $6.42 | $5.03 | $3.65 |
Total Assets | $20.46B | $18.74B | $15.44B | $12.97B |
Total Liabilities | $2.52B | $2.21B | $2.04B | $1.86B |
Cash & Equivalents | $3.37B | $2.03B | $2.75B | $1.58B |
Free Cash Flow OCF − CapEx | $2.49B | $1.30B | $749.60M | $958.40M |
Shares Outstanding | 355.10M | 356.60M | 352.30M | 350.00M |